166 related articles for article (PubMed ID: 10938200)
1. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Sghirlanzoni A; Solari A; Ciano C; Mariotti C; Fallica E; Pareyson D
Neurol Sci; 2000 Feb; 21(1):31-7. PubMed ID: 10938200
[TBL] [Abstract][Full Text] [Related]
2. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
[TBL] [Abstract][Full Text] [Related]
4. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
6. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
8. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.
Cocito D; Durelli L; Isoardo G
Acta Neurol Scand; 2003 Oct; 108(4):274-80. PubMed ID: 12956862
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
13. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.
Kuwabara S; Misawa S; Mori M; Tamura N; Kubota M; Hattori T
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):66-70. PubMed ID: 16361595
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiological and clinical aspects of CIDP].
Viala K
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S31-5. PubMed ID: 18087227
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
17. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
Leitch MM; Sherman WH; Brannagan TH
Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
[TBL] [Abstract][Full Text] [Related]
18. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA
Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
[TBL] [Abstract][Full Text] [Related]
19. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Henderson RD; Sandroni P; Wijdicks EF
J Neurol; 2005 Oct; 252(10):1235-7. PubMed ID: 15940387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
